Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial).

Author:

Cavo Michele1,Palumbo Antonio2,Zweegman Sonja3,Dimopoulos Meletios A.4,Hajek Roman5,Pantani Lucia1,Beksac Meral6,Wester Ruth7,Johnsen Hans E.8,Mellqvist Ulf-Henrik9,Petrucci Maria Teresa10,Driessen Christoph11,Di Raimondo Francesco12,Troia Rossella2,Pezzi Annalisa1,van der Holt Bronno13,Wu Ka Lung14,Ludwig Heinz15,Gay Francesca2,Sonneveld Pieter16

Affiliation:

1. Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy;

2. Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Torino, Italy;

3. Department of Hematology, VU University Medical Center, Amsterdam, Netherlands;

4. School of Medicine, National and Kapodistrian University of Athens, Athens, Greece;

5. Masaryk University Hospital, Brno, Czech Republic;

6. Ankara Universitesi Tip Fakultesi, Ankara, Turkey;

7. Erasmus Medical Center, Department of Hematology, Rotterdam, Netherlands;

8. Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark;

9. South Elvsborg Hospital, Borås, Sweden;

10. Department of Hematology, Sapienza University of Rome, Rome, Italy;

11. Kantonsspital St. Gallen, St. Gallen, Switzerland;

12. Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy;

13. HOVON Data Center, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, Netherlands;

14. ZNA Stuivenberg, Department of Hematology, Antwerp, Belgium;

15. Wilhelminen Cancer Research Institute, Wilhelminenspital, Department of Medicine, Center of Oncology, Hematology and Palliative Care, Vienna, Austria;

16. Erasmus Medical Center, Rotterdam, Netherlands;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3